In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 66, Issue 2, 2007, Pages 296-301

  Patel, Sonal R ^a   Zhong, Hui ^a   Sharma, Ashutosh ^a   Kalia, Yogeshvar N ^b,c  

^a Vyteris Inc   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c Ctr Interuniv Rech d'Enseignement   (France)

Author keywords

5HT1B 1D agonist; In vivo; Iontophoresis; Migraine; Non invasive; Sumatriptan; Transdermal

Indexed keywords

SUMATRIPTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; NONHUMAN; PH; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION CHAMBERS, CULTURE; DOSAGE FORMS; DRUG COMPOUNDING; FEASIBILITY STUDIES; FEMALE; HYDROGEN-ION CONCENTRATION; IONTOPHORESIS; ORGAN CULTURE TECHNIQUES; SEROTONIN AGONISTS; SKIN ABSORPTION; SUMATRIPTAN; SWINE;

EID: 34247539073     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.11.001     Document Type: Article

References (22)

1. Humphrey P.P.A., and Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol. Sci. 12 (1991) 444-446
2. Tfelt-Hansen P., De Vries P., and Saxena P.R. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60 (2000) 1259-1287
3. 1B/1D agonists. Arch. Intern. Med. 161 (2001) 2545-2553
4. Duquesnoy C., Mamet J.P., Sumner D., and Fuseau E. Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration. Eur. J. Pharm. Sci. 6 (1998) 99-104
5. Welch K.M.A., Mathew N.T., Stone P., Rosamund W., Saiers J., and Gutterman D. Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalgia 20 (2000) 687-695
6. Adlard M., Okafo G., Meenan E., and Camilleri P. Rapid estimation of octanol-water partition coefficients using deoxycholate micelles in capillary electrophoresis. Chem. Commun. 21 (1995) 2241-2243
7. Femenía-Font A., Balaguer-Fernández C., Merino V., and López-Castellano V.RodillaA. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate: effect of current density and ionic strength. Eur. J. Pharm. Biopharm. 61 (2005) 50-55
8. Femenía-Font A., Padula C., Marra F., Balaguer-Fernández C., Merino V., López-Castellano A., Nicoli S., and Santi P. Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan. J. Pharm. Sci. 95 (2006) 1561-1569
9. Kalia Y.N., Naik A., Garrison J., and Guy R.H. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 619-658
10. Viscusi E.R., Reynolds L., Chung F., Atkinson L.E., and Khanna S. Patient-controlled transdermal fentanyl hydrochloride vs. intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA 291 (2004) 1333-1341
11. Femenía-Font A., Balaguer-Fernández C., Merino V., and López-Castellano A. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength. J. Pharm. Sci. 94 (2005) 2183-2186
12. Patel S.R., Zhong H., Sharma A., and Kalia Y.N. Transdermal iontophoretic delivery of sumatriptan in vivo. Cephalgia 24 (2004) 793
13. Ledger P.W. Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Deliv. Rev. 9 (1992) 289-307
14. Cheng K.N., Redrup M.J., Barrow A., and Williams P.N. Validation of a liquid chromatographic tandem mass spectrometric method for the determination of sumatriptan in human biological fluids. J. Pharm. Biomed. Anal. 17 (1998) 339-408
15. Marro D., Guy R.H., and Delgado-Charro M.B. Characterization of the iontophoretic permselectivity properties of human and pig skin. J. Control. Release 70 (2001) 213-217
16. Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Del. Rev. 9 (1992) 201-237
17. Kasting G.B., and Keister J.C. Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J. Control. Release 8 (1989) 195-210
18. Padmanabhan R.V., Phipps J.B., Lattin G.A., and Sawchuk R.J. In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J. Control. Release 11 (1990) 123-135
19. Singh P., Boniello S., Liu P., and Dinh S. Transdermal iontophoretic delivery of methylphenidate HCl in vitro. Int. J. Pharm. 178 (1999) 121-128
20. Marro D., Kalia Y.N., Delgado-Charro M.B., and Guy R.H. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res. 18 (2001) 1701-1708
21. Jadoul A., Mesens J., Caers W., de Beukelaar F., Crabbé R., and Préat V. Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetics data. Pharm. Res. 13 (1996) 1348-1353
22. Femenía-Font A., Balaguer-Fernández C., Merino V., and López-Castellano A. Combination strategies for enhancing transdermal absorption of sumatriptan through skin. Int. J. Pharm. 323 (2006) 125-130